Global Liver Institute
News
GLOBAL LIVER INSTITUTE
Why Hepatitis C Treatment Matters: Improving Patient Outcomes Beyond Liver Health
Hepatitis C continues to be a significant public health concern with effects that reach beyond liver function. As a physician, you’re likely familiar with the chronic health challenges that accompany hepatitis C, especially in patients with multiple comorbidities.
Congress goes into recess in October while staff prepare for a potentially busy November lame-duck session – Liver Health Policy Update
Congress is in recess with Representatives and Senators back in districts and states connecting with their constituents prior to the elections. Their staff are working hard to prepare for what many hope to be a productive November legislative session where some legislative priorities may finally make it to final passage.
Cancer Care for the Underrepresented #Octoberis4Livers – Liver Cancer News
Welcome back to Liver Cancer News! As we mark Liver Cancer Awareness Month in October, we’re emphasizing the critical role of education and awareness in the fight against liver cancer through the #OctoberIs4Livers campaign. Read on for more information about the campaign and for updates on liver cancer care & prevention – especially for populations that face disparities in liver cancer care.
Emerging Evidence in Liver Health: GLP-1, Pollution, and More – Fatty Liver Disease News
Despite awareness efforts, fatty liver disease remains largely overlooked in major global health strategies.
2025 ICD-10 Coding will include code for cholestatic pruritus – Pediatric & Rare Liver Diseases News
Ipsen has achieved progress in the fight against cholestatic diseases, marking two important victories for patients.
As Deadly Liver Cancer Rises, Collaborative, Targeted Prevention and Surveillance Necessary
Global Liver Institute (GLI) launches its seventh annual #OctoberIs4Livers campaign to raise awareness of and address disparities in liver cancer in recognition of Liver Cancer Awareness Month.
Congress reconvenes in September for its last push to legislate before the November elections. – Liver Health Policy Update
Congress is entering a very busy work period in September, the last before the November elections. GLI is preparing for its Advanced Advocacy Academy (A3) and subsequent day on Capitol Hill to advocate for legislation!
Millennials and Generation X Face Higher Risk of Liver Cancer Than Previous Generations – Liver Cancer News
Thank you for being a part of Liver Cancer News! As we gear up for Liver Cancer Awareness Month next month, we are thrilled to announce the launch of a comprehensive patient toolkit designed to support our community throughout their cancer journey.
Let’s Ensure Access to Treatment for PBC Patients – Pediatric & Rare Liver Diseases News
With advancements in second-line treatments for PBC in 2024, both current and new treatment options must remain available, so that every patient can choose the treatment that best meets their needs.
New Guidelines & Actions for Change – Fatty Liver Disease News
New Clinical Practice Guidelines for MASLD, developed jointly by EASL, EASD, and EASO, update the 2016 guidelines to reflect recent advancements.
Global Liver Institute Welcomes Larry R. Holden as CEO
The Board of Directors of Global Liver Institute (GLI), the premier liver patient advocacy organization, has appointed Larry R. Holden as the organization’s Chief Executive Officer, as of September 2024.
More Than a Cure, a Path to Improvement: Hepatitis C Treatment
Hepatitis C infection, an infection of the liver by the hepatitis C virus, is a major global health concern, affecting millions.